Edwards Lifesciences Corporation stock page - price, fundamentals, dividends - iOCharts

EW

116.07
-0.92 (-0.79%)
Edwards Lifesciences Corporation (NYSE, USD)
Healthcare >
Medical Devices
Market cap
72.15B
Ent value
73.53B
Price/Sales
16.45
Price/Book
15.49
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
87.63
Forward P/E
46.06
PEG
8.54
EPS growth
5.80%
1 year return
51.73%
3 year return
34.43%
5 year return
25.09%
10 year return
25.24%
Last updated: 2021-10-27

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open116.60
Daily high116.90
Daily low114.69
Daily Volume1.63M
All-time high122.75
1y analyst estimate100.00
Beta1.09
EPS (TTM)1.32
Dividend per share-
Ex-div date-
Next earnings date27 Oct 2021

Downside potential

Loading...
Downside potential data
EWS&P500
Current price drop from All-time high-5.44%-0.44%
Highest price drop-50.47%-56.47%
Date of highest drop1 Nov 20009 Mar 2009
Avg drop from high-10.01%-11.44%
Avg time to new high13 days12 days
Max time to new high516 days1805 days

DIVIDENDS

EW does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E87.63
Price to OCF68.44
Price to FCF111.52
Price to EBITDA70.47
EV to EBITDA71.82

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales16.45
Price to Book15.49
EV to Sales16.76

FINANCIALS

Per share

Loading...
Per share data
Current share count621.64M
EPS (TTM)1.32
FCF per share (TTM)1.04

Income statement

Loading...
Income statement data
Revenue (TTM)4.39B
Gross profit (TTM)3.31B
Operating income (TTM)1.32B
Net income (TTM)823.40M
EPS (TTM)1.32
EPS (1y forward)2.52

Margins

Loading...
Margins data
Gross margin (TTM)75.36%
Operating margin (TTM)30.02%
Profit margin (TTM)18.77%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.17B
Net receivables664.30M
Total current assets3.07B
Goodwill1.17B
Intangible assets330.30M
Property, plant and equipment1.51B
Total assets7.21B
Accounts payable987.80M
Short/Current long term debt688.80M
Total current liabilities799.00M
Total liabilities2.56B
Shareholder's equity4.66B
Net tangible assets3.44B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.05B
Capital expenditures (TTM)407.30M
Free cash flow (TTM)647.00M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity18.00%
Return on Assets11.38%
Return on Invested Capital14.27%
Cash Return on Invested Capital11.21%
COMPANY DETAILS
EW (Edwards Lifesciences Corporation) company logo
Marketcap
72.15B
Marketcap category
Large-cap
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Employees
14900
Investor relations
SEC filings
CEO
Michael Mussallem
Country
USA
City
Irvine
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Strong sales growth across all four products group along with increased adoption of the PASCAL platform drove Edwards Lifesciences' (EW) third-quarter revenues.
October 28, 2021
EW earnings call for the period ending September 30, 2021.
October 28, 2021
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 1.89% and -0.92%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
October 27, 2021
The pandemic continued to dog Edwards Lifesciences and Boston Scientific in the third quarter, the companies said Wednesday — leading EW stock and BSX stock to dive.
October 27, 2021
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended September 30, 2021.
October 27, 2021
With the pandemic raging on, testing, vaccine and therapeutic makers witness huge market adoption of their COVID-related support products in Q3.
October 26, 2021
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2021 after the market closes on Wednesday, October 27, 2021, and will host a conference call...
October 20, 2021
OCPNY vs. EW: Which Stock Is the Better Value Option?
October 19, 2021
The Zacks Analyst Blog Highlights: Edwards Lifesciences, DexCom, Twitter, Cigna Corp and Restaurant Brands
October 18, 2021
Today's Research Daily features new research reports on 12 major stocks, including Edwards Lifesciences Corporation (EW), DexCom, Inc. (DXCM), and Twitter, Inc. (TWTR).
October 15, 2021
Next page